NASDAQ$MURA
Mural Oncology Plc · Q4 2024 earnings
Q4 2024 earnings · · Before market open · Investor relations
Reports awaiting report
Mural Oncology hasn't published Q4 2024 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.
Most recent report Q3 2025
- Revenue
- -$1.00
- EPS
- -$0.21
Year-ago · Q4 2023 Q4 2023
- Revenue
- $2.62M
- EPS
- -$3.57
FY2024 consensus Analyst consensus
- Revenue
- $0.00
- EPS
- -$7.56
Revenue & EPS history
Mural Oncology · Revenue · Quarterly
-$1
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 7 quarterly earnings reports · overlaid with Q4 2024
-9.3%
Avg return
Earnings day
-9.4%
Avg return
5 days after
+5.1%
Avg return
30 days after
23%
3 / 13 earnings
Positive
+14.6%
Q4 2023
Best reaction
-61.6%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | — | — | — | |
| Q3 2025 | -0.5% | -0.5% | — | |
| Q2 2025 | -20.2% | -30.3% | -9.2% | |
| Q1 2025 | -4.4% | -4.7% | -10.9% | |
| Q4 2024 | -61.6% | -65.0% | -31.3% | |
| Q3 2024 | -0.9% | -4.8% | +2.3% | |
| Q2 2024 | +1.0% | +4.5% | +0.6% | |
| Q1 2024 | +2.7% | +4.0% | -12.0% | |
| Q4 2023 | +14.6% | +13.2% | -16.7% | |
| Q1 2023 | -10.4% | -7.7% | +27.7% | |
| Q2 2023 | -10.4% | -7.7% | +27.7% | |
| Q3 2022 | -10.4% | -7.7% | +27.7% | |
| Q4 2022 | -10.4% | -7.7% | +27.7% | |
| Q3 2023 | -10.4% | -7.7% | +27.7% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro